Kalehua Capital Management »

Karyopharm Therapeutics shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.7M 686k 9.77

More positions owned by Kalehua Capital Management

Ea Series Trust Alpha Arch 1-3 (BOXX)
Veradermics Common Stock (MANE)
Veradermics Coomon Stock (MANE)
X4 Pharmaceuticals Com New (XFOR)
X4 Pharmaceuticals Com New (XFOR)
Compass Pathways Sponsored Ads (CMPS)
Compass Pathways Sponsored Ads (CMPS)
Surrozen Com New (SRZN)
Surrozen Com New (SRZN)
Aclaris Therapeutics (ACRS)
Aclaris Therapeutics (ACRS)
Sionna Therapeutics (SION)
Sionna Therapeutics (SION)
Inhibikase Therapeutics Com New (IKT)
Inhibikase Therapeutics Com New (IKT)

View all positions for Kalehua Capital Management

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics